The Full Wiki

More info on Fesoterodine

Fesoterodine: Wikis

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
[2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
CAS number 286930-03-8
ATC code G04BD11
PubChem 6918558
Chemical data
Formula C 26H37NO3  
Mol. mass 411.278 g/mol
Pharmacokinetic data
Bioavailability 52% (active metabolite)
Protein binding 50% (active metabolite)
Metabolism Hepatic (CYP2D6- and 3A4-mediated)
Half life 7–8 hours (active metabolite)
Excretion Renal (70%) and fecal (7%)
Therapeutic considerations
Licence data

EU EMEA:linkUS FDA:link

Pregnancy cat. C(US)
Legal status Prescription only
Routes Oral

Fesoterodine (INN, brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome.[1] It was approved by the European Medicines Agency in April 2007[2] and was approved by the US Food and Drug Administration on October 31, 2008.[3]

Fesoterodine is a prodrug. It is broken down into its active metabolite, 5-hydroxymethyl tolterodine, by plasma esterases.


Got something to say? Make a comment.
Your name
Your email address